Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients

NCT01927224 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Chagas Disease

Interventions

DRUG: Nifurtimox (BAYa2502) (4 x 30 mg tablet)
DRUG: Nifurtimox (BAYa2502) (slurry of 4 x 30 mg tablets in tap water)
DRUG: Nifurtimox (BAYa2502) (120 mg tablet)

Sponsor

Bayer